NVAX Financial Facts

Income tax expense: 0
Research and development: 19.22M
See Full Income Statement

Current portion of notes payable: 795K
Non-current portion of notes payable: 571K
See Full Balance Sheet

Novavax, Inc. (NVAX) Earnings

  |   Expand Research on NVAX
Next EPS Date 5/7/15 *Est. EPS Growth Rate -85.7% *Last Qtr.
Average EPS % Beat Rate -22.8% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +0.2% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/26/15 Q414 -$0.13-$0.08 -$0.05N/A$9.6M N/A Details
11/7/13 Q313 N/A-$0.06 N/A N/A$4.56M N/A N/A N/A
3/10/14 Q413 -$0.07-$0.08 +$0.01$8.75M$6.22M N/A Details
11/5/14 Q314 -$0.08-$0.07 -$0.01$8.2M$9.2M N/A Details
8/6/14 Q214 -$0.08-$0.07 -$0.01$8.26M$8.74M N/A Details
5/7/14 Q114 -$0.07-$0.07 $0.00$7.5M$3.8M N/A Details
8/8/13 Q213 -$0.08-$0.06 -$0.02$3.52M$4.45M N/A Details
3/28/11 Q410 -$0.06-$0.09 +$0.03$51K$110K N/A Details